VKH
NAGE

Virtu KCG Holdings’s Niagen Bioscience NAGE Stock Holding History

Virtu KCG Holdings’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$44K Buy
+11,549
New +$36.6K ﹤0.01% 2620
2016
Q4 		– Sell
-12,181
Closed -$36K – 3862
2016
Q3 		$36K Sell
12,181
-25,405
-68% -$93.3K ﹤0.01% 2835
2016
Q2 		$156K Buy
+37,586
New +$178K ﹤0.01% 2412

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu KCG Holdings's NAGE Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Niagen Bioscience (NAGE) in Q2 2017: 11,549 shares worth $44K. The stake represents ﹤0.01% of the portfolio and ranks #2620 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in NAGE as recently as Q3 2016.

Virtu KCG Holdings first reported a position in NAGE in Q2 2016 and has held it in 3 quarters since. The position peaked at $156K in Q2 2016. 46 funds tracked by Wall St. Rank hold NAGE as of Q2 2017.

  • Virtu KCG Holdings held 11,549 shares of Niagen Bioscience worth $44K as of Q2 2017.
  • Niagen Bioscience was a new Virtu KCG Holdings position in Q2 2017.
  • Niagen Bioscience made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2620 holding.
  • Virtu KCG Holdings first reported a position in Niagen Bioscience in Q2 2016 and has held it in 3 quarters since.
  • Virtu KCG Holdings's Niagen Bioscience position peaked at $156K in Q2 2016.
  • 46 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.